Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT02748850
Eligibility Criteria:
Inclusion Criteria:
* Subject, man or woman, whose age is above 18 years
* Subject whose physical and mental condition allows him to understand the information leaflet
* Presenting acute leukemia and / or refractory anemia with excess blasts and blasts with a higher peripheral blood 5%. For leukemic Group
* Subject to benefit from apheresis for autologous stem cell transplantation as part of a non-myeloid hematological malignancy. For the Group Cytapheresis
* Subject affiliated to the social security scheme
* Subject has signed an informed consent
* Subject with a medical examination adapted to the study was conducted
Exclusion Criteria:
* Subject, man or woman, whose age is above 18 years
* Subject previously treated with chemotherapy for his leukemia. For leukemic Group
* Subject considered "vulnerable person" (Major deprived of freedom, under guardianship, pregnant and lactating women and minors)
* Subject refusing to participate in the study
* Subject not having signed an informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02748850
Study Brief:
Protocol Section:
NCT02748850